The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Feasibility of surgical orchiectomy in prostate cancer patients on long term luteinizing hormone-releasing hormone (LHRH) agonist therapy.
 
Alon Lazarovich
No Relationships to Disclose
 
Walter Stadler
Stock and Other Ownership Interests - Fortress Biotech
Consulting or Advisory Role - AstraZeneca; Aveo; CVS Caremark; Merck; Pfizer; Treadwell Therapeutics; Xencorp
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Medivation (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Corvus Pharmaceuticals (Inst); Eisai (Inst); Exelixis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Johnson & Johnson (Inst); Merck (Inst); Millennium (Inst); Novartis (Inst); Pfizer (Inst); Seagen (I); Tesaro (Inst); X4 Pharma (Inst); Xencor (Inst)
Expert Testimony - Apotex; Sandoz; US Dept of Justice; US Dept of Justice
Other Relationship - American Cancer Society; UpToDate
 
Scott Eggener
No Relationships to Disclose
 
Ashley Page
Employment - University of Chicago
 
Brian Heiss
No Relationships to Disclose
 
Daniel Geynisman
Honoraria - Targeted Oncology
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Exelixis; Merck; Pfizer; Seattle Genetics/Astellas
Research Funding - Arvinas (Inst); Astellas Pharma (Inst); CG Oncology (Inst); Harpoon therapeutics (Inst); Merck (Inst)
 
Natalie Reizine
Consulting or Advisory Role - Curium Pharma; Tempus
Speakers' Bureau - AstraZeneca; EMD Serono; Janssen Oncology; Merck; Tempus